Zach Scheiner resigned from the Board of Directors and all its committees effective June 30, 2026, without any disagreement with the Company. The Board size was subsequently reduced to six members, and Jeff George was appointed to the Audit Committee. LENZ Therapeutics, Inc. is a biotechnology company focused on ophthalmic therapies.
